Company intelligence / Profile preview

Allerpha International

Ownership: Private
Development stage: Other

Overview

Allerpha International is a pharmaceutical company specializing in the development and commercialization of treatments for allergic and respiratory diseases. The company focuses on providing high-quality, affordable therapeutic solutions for conditions such as allergic rhinitis, asthma, and chronic urticaria. Allerpha's portfolio typically includes a range of antihistamines and respiratory medications designed to improve patient quality of life. Headquartered in Hong Kong, the company operates with a significant focus on the Asia-Pacific market, leveraging strategic partnerships for distribution and manufacturing.

Therapeutic areas: ImmunologyPulmonologyDermatology
Modalities: Small moleculeVaccine
Industry: Biotech

Beyond the preview

Go deeper on Allerpha International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allerpha International.